Ireland - English - HPRA (Health Products Regulatory Authority)

aspire pharma limited - bimatoprost; timolol maleate - eye drops, solution - 0.3/5 milligram(s)/millilitre - timolol, combinations

Ireland - English - HPRA (Health Products Regulatory Authority)

european regulatory affairs t/a ivowen - bimatoprost; timolol maleate - eye drops, solution - 0.3/5 milligram(s)/millilitre - timolol, combinations

Ireland - English - HPRA (Health Products Regulatory Authority)

laboratoires thea - bimatoprost - eye gel in single-dose container - bimatoprost

Ireland - English - HPRA (Health Products Regulatory Authority)

morningside healthcare (malta) limited - bimatoprost; timolol maleate - eye drops, solution - timolol, combinations

New Zealand - English - Medsafe (Medicines Safety Authority)

multichem nz limited - bimatoprost 0.3 mg/ml;  ;   - eye drops, solution - 0.3 mg/ml - active: bimatoprost 0.3 mg/ml     excipient: benzalkonium chloride citric acid monohydrate dibasic sodium phosphate heptahydrate hydrochloric acid purified water sodium chloride sodium hydroxide - monotherapy for the reduction of elevated intraocular pressure (iop) in patients with chronic glaucoma or ocular hypertension; or as adjunctive therapy in patients not adequately controlled on other agents.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - bimatoprost, quantity: 0.3 mg/ml - eye drops, solution - excipient ingredients: citric acid; sodium hydroxide; dibasic sodium phosphate; benzalkonium chloride; sodium chloride; water for injections; hydrochloric acid - the reduction of elevated intraocular pressure, or open angle glaucoma, as first line therapy or monotherapy or as adjunctive therapy to topical beta-blockers.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

aspire pharma ltd - bimatoprost - eye drops - 300microgram/1ml

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - bimatoprost, quantity: 0.3 mg/ml - eye drops, solution - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide; citric acid monohydrate; sodium chloride; dibasic sodium phosphate heptahydrate; benzalkonium chloride - bimatoprost is indicated for the reduction of elevated intraocular pressure, or open angle glaucoma, as first line therapy or monotherapy or as adjunctive therapy to topical beta-blockers.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - bimatoprost, quantity: 0.3 mg/ml - eye drops, solution - excipient ingredients: dibasic sodium phosphate heptahydrate; sodium chloride; citric acid monohydrate; water for injections; sodium hydroxide; hydrochloric acid; benzalkonium chloride - bimatoprost is indicated for the reduction of elevated intraocular pressure, or open angle glaucoma, as first line therapy or monotherapy or as adjunctive therapy to topical beta-blockers.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - bimatoprost, quantity: 0.3 mg/ml - eye drops, solution - excipient ingredients: hydrochloric acid; sodium hydroxide; dibasic sodium phosphate heptahydrate; citric acid monohydrate; water for injections; sodium chloride; benzalkonium chloride - bimatoprost is indicated for the reduction of elevated intraocular pressure, or open angle glaucoma, as first line therapy or monotherapy or as adjunctive therapy to topical beta-blockers.